Abstract

IL-33 is upregulated in ulcerative colitis and has a protective role in chemically-induced acute murine colitis. We aimed to determine whether IL-33 influences Il10−/− chronic colitis and its cellular source in health and during colitis. Il10−/−Il33−/− and Il10−/−Il33+/+ littermates developed colitis of similar severity. Colon Il33 was induced in WT and Il10−/− mice exposed to DSS, but not in unchallenged Il10−/− mice with colitis. Il33-citrine reporter mice showed that Il33-citrine colocalized with α-smooth muscle actin+ myofibroblasts and vimentin+ fibroblasts in WT mice. Citrine+CD74+CD90hi inflammatory fibroblasts were increased with DSS treatment. IL-1β induced Il33 expression in colon myofibroblasts, but colon Il33 expression did not differ between DSS-treated WT and Il1r1−/− mice. In conclusion, deficiency of IL-33 does not alter the severity of chronic colitis in Il10−/− mice. Induction of Il33 upon DSS exposure in WT and Il10−/− mice, but not in unchallenged Il10−/− mice, suggests epithelial injury induces colon IL-33. Fibroblasts are the primary colonic source of IL-33 and IL-33-expressing CD90hiCD74+ fibroblasts are increased during DSS-induced colitis. IL-1β induces Il33 in colon myofibroblasts in vitro, but signaling through the IL-1R1 is not necessary for induction of IL-33 in DSS-induced colitis.

Highlights

  • IL-33 is upregulated in ulcerative colitis and has a protective role in chemically-induced acute murine colitis

  • During acute colitis induced with DSS, we show there is an expansion of IL-33-producing inflammatory fibroblasts similar to those reported in human ulcerative colitis (UC)

  • We found that neither Il33 expression, nor IL-33 producing fibroblasts were increased during the development of chronic colitis in Il10-deficient mice, Il33 expression could be induced in Il10−/− mice by epithelial injury with DSS

Read more

Summary

Introduction

IL-33 is upregulated in ulcerative colitis and has a protective role in chemically-induced acute murine colitis. Induction of Il33 upon DSS exposure in WT and Il10−/− mice, but not in unchallenged Il10−/− mice, suggests epithelial injury induces colon IL-33. A protective role has been shown for IL-33 in other models of colitis, we could find no differences in colitis development or severity in Il10−/− compared to Il10−/−Il33−/− mice. Using IL-33-citrine reporter mice (Il33Cit/+), we show that ­vimentin+CD90+ fibroblasts are the source of IL-33 at baseline and this population increases in DSS-induced. IL-1β induced IL-33 expression in vitro, using Il1r1−/− mice, we showed this signaling pathway is not required for Il33 induction during DSS-induced colitis. ­CD90+CD74+ inflammatory fibroblasts express IL-33 and are increased in DSS-induced colitis, indicating this population is likely responsible for the increases in Il33 in acute colitis induced by epithelial damage

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call